Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq:IINNW) (“Inspira” or the “Company”), a leader in life-support technology innovation, has announced the appointment of Mr. Tal Parnes as the new chairman of the board of directors, effective February 1, 2025. https://mma.prnewswire.com/media/2602501/Tal_Parnes.jpg Mr. Parnes brings a wealth of experience and expertise to his new role at Inspira. […]

— Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy — Financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring revenues across B2B (Business-to-Business) andpharma channels DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a prominent leader in the global digital health industry,

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today provided the following letter to shareholders from the Company's, Chairman and CEO,Dr. Amit Kumar: https://mma.prnewswire.com/media/602982/ITUS_Corporation_Logo.jpg To our valued shareholders, I am excited to highlight our key achievements from the past year and share our

PharmaScroll, a renowned market research and business analytics company, continues to push boundaries in the AI space with the launch of its latest innovation, Self-Serve AI, a generative AI-based advanced research and analytics tool tailored to professionals in the healthcare and pharmaceutical domains. The tool is designed to provide deep, actionable insights, addressing both qualitative

Partnership aims to reduce environmental impacts and build more sustainable railroad infrastructure in North America Supports expanded production, product development and market adoption of Evertrak's sustainable, composite railroad ties made from recycled plastic Evertrak, the leading manufacturer of composite railroad ties made from recycled plastic, today announced a strategic partnership with Sumitomo Corporation of Americas

Tantech Holdings Ltd (NASDAQ: TANH) (“Tantech” or the “Company”) today announced that on January 16, 2025, its subsidiary,Gohomeway Group Inc., completed the registration of the “GOHOMEWAY” trademark in the United States. The registration, filed under application number 98967272, marks a significant milestone in the company's growth. The “GOHOMEWAY” trademark spans a wide range of categories,

Recognized for Outstanding Security Excellence, Strengthening Customer Trust and Global Competitiveness RSUPPORT Co., Ltd., a leading provider of remote solutions, announced today that its Global R&D Center has achieved the ISO/IEC 27001:2022 certification, the international standard for information security management systems (ISMS). https://mma.prnewswire.com/media/2598446/RSUPPORT_Global_R_D_Center.jpg ISO/IEC 27001:2022, jointly established by the International Organization for Standardization (ISO) and

Hesai Technology (Nasdaq: HSAI), the global leader in automotive lidar technology, today announced that it has secured design wins for multiple Chery Automobile models. The models are expected to enter mass production in the second half of 2025 and will be equipped with the newest generation of Hesai's ultra-compact high-performance ATX lidar. Chery's vehicle line-up

Nature's Miracle Holding Inc. (OTC PINK: NMHI) (“Nature's Miracle” or the “Company”), a leader in vertical farming technology and infrastructure, today announced that on January 19, 2025, it has signed a non-binding letter of intent (“LOI”) to acquire 100% of Pangea Global Technologies, Inc. (“Pangea”), a leading manufacturer of LED lighting and technology solutions provider.

Expanding Partnerships with Major Industry Players Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that its wholly owned subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd. (“Hupan Pharmaceutical”), has entered into two distribution agreements with Hubei Kelun